Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exforge vs Diovan in essential hypertension
NCT01001572Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of amlodipine + valsartan in essential hypertension, sponsored by Novartis. Started Sep 2009; status: completed.
02
Drugs
amlodipine + valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01001572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001572.